发明名称 Rationally designed antibodies
摘要 Antibodies or fragments thereof having CDR regions replaced or fused with biologically active peptides are described. Flanking sequences may optionally be attached at one or both the carboxy-terminal and amino-terminal ends of the peptide in covalent association with adjacent framework regions. Compositions containing such antibodies or fragments thereof are useful in therapeutic and diagnostic modalities.
申请公布号 US8771932(B2) 申请公布日期 2014.07.08
申请号 US200912321828 申请日期 2009.01.26
申请人 Alexion Pharmaceuticals, Inc. 发明人 Bowdish Katherine S.;Renshaw Mark;Frederickson Shana
分类号 A61K35/14;C07K16/00;C07K7/00 主分类号 A61K35/14
代理机构 Nelson Mullins Riley & Scarborough LLP 代理人 Nelson Mullins Riley & Scarborough LLP ;Remillard, Esq. Jane E.;Frank Christopher L.
主权项 1. A method of stimulating proliferation, differentiation, or growth of promegakaryocytes or megakaryocytes, comprising contacting promegakaryocytes or megakaryocytes with an effective amount of an immunoglobulin molecule or fragment thereof comprising one or more thrombopoietin (TPO) mimetic peptides, wherein: a) said one or more TPO mimetic peptides replace at least a portion of one or more complementarity determining regions (CDRs) or b) said one or more TPO mimetic peptides are fused to one or more CDRs, wherein said immunoglobulin molecule or fragment thereof comprising the one or more TPO mimetic peptides binds to a TPO receptor, and wherein said immunoglobulin or fragment thereof comprising one or more TPO mimetic peptides comprises one or more immunoglobulin framework regions.
地址 Cheshire CT US